Lifecore Biomedical Inc (LFCR)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-02-26	2022-11-27
Periodenlänge	3 Monate	3 Monate
Revenues	21.37% 26.54	21.86
Cost Of Revenue	11.14% 17.99	16.18
Gross Profit	50.52% 8.548	5.679
Operating Expenses	36.70% 15.08	11.03
Interest Income/Expense	33.97% 4.855	3.624
Benefits Costs and Expenses	21.68% 37.80	31.06
Costs And Expenses	21.68% 37.80	31.06
Operating Income/Loss	22.03% -6.531	-5.352
Income/Loss From Continuing Operations Before Tax	22.43% -11.26	-9.197
Income Tax Expense/Benefit	1,650% 0.07	0.004
Income/Loss From Continuing Operations After Tax	23.14% -11.33	-9.201
Income/Loss From Discontinued Operations, Net Of Tax	598.39% -25.18	-3.605
Net Income/Loss	185.08% -36.51	-12.81
Preferred Stock Dividends And Other Adjustments	-	-
Attributable To Noncontrolling Interest	-	-
Basic Average Shares	2.26% 30.30	29.63
Diluted Average Shares	2.26% 30.30	29.63
Basic Earnings Per Share	179.07% -1.20	-0.43
Diluted Earnings Per Share	179.07% -1.20	-0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-

ELAN

$12.67

0.88%

LNTH

$114.96

0.42%

ITCI

$89.24

3.56%

CTLT

$58.48

0.36%

NBIX

$121.53

0.83%

VTRS

$11.61

1.40%